Attached files

file filename
10-Q - FORM 10-Q - TITAN PHARMACEUTICALS INCv437806_10q.htm
EX-31.1 - EXHIBIT 31.1 - TITAN PHARMACEUTICALS INCv437806_ex31-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with this quarterly report on Form 10-Q of Titan Pharmaceuticals, Inc. (the “Company”) for the period ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 10, 2016

 

/s/ Sunil Bhonsle   
Name:   Sunil Bhonsle  
Title: President and Chief Executive Officer  
  (Principal Executive Officer and Principal  
  Financial Officer)